Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
LEXX · NASDAQ · Pharmaceutical Preparations
$4.49+0.21 (+4.91%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day, not a live quote
Lexaria Bioscience (LEXX) · oqro.io/stocks/LEXX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Armistice Capital, LLC now owns 8.2% of LEXX as a passive investorSourceInsider trade · Traded Jul 29, 2025 · Filed Jul 30, 2025
CEO purchased ~$14K of LEXX shares in the open marketSourceInsider trade · Traded Jul 29, 2025 · Filed Jul 30, 2025
Director purchased ~$4.5K of LEXX shares in the open marketSourceInsider trade · Traded Jul 29, 2025 · Filed Jul 30, 2025
Director purchased ~$14K of LEXX shares in the open marketSourceInsider trade · Traded Jul 30, 2025 · Filed Jul 30, 2025
Director purchased ~$11K of LEXX shares in the open marketSourceInsider trade · Traded Jul 29, 2025 · Filed Jul 30, 2025
Director purchased ~$5K of LEXX shares in the open marketSourceInsider trade · Traded Jul 29, 2025 · Filed Jul 30, 2025
Officer purchased ~$683 of LEXX shares in the open marketSourceInsider trade · Traded Dec 3, 2024 · Filed Dec 3, 2024
CEO purchased ~$67K of LEXX shares in the open marketSourceInsider trade · Traded Dec 2, 2024 · Filed Dec 3, 2024
CEO purchased ~$51K of LEXX shares in the open marketSource